While GPER expression was detected in a high percentage of these cancer types, we observed heterogeneity between cases of the same cancer type, suggesting that GPER protein expression in patient samples may be a useful biomarker for GPER-directed therapies (35, 36). The gene discussed is GPER1; the disease is cancer.